Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 2551 AL 2565

From Queasy to Rigid - An amendment on the administration of contraindicated antiemetics in hospitalized people with Parkinson's disease

Piccinin CC, Yu JRT, Sonneborn C, Hogue O, Popov R, Ghosh D, Brooks A, Liao J, Shaffer S, Sperling SA, Walter BL.

Parkinsonism Relat Disord. 2025 May;134:107782. doi: 10.1016/j.parkreldis.2025.107782. Epub 2025 Mar 11.

Effect of an adapted physical activity program in Parkinson's disease: A randomized controlled study (APA-Park)

Zanchet C, Lambert C, Boyer T, Pereira B, Derost P, Debilly B, Duclos M, Boisseau N, Marques A.

Parkinsonism Relat Disord. 2025 May;134:107777. doi: 10.1016/j.parkreldis.2025.107777. Epub 2025 Mar 10.

Quantitative corneal nerve beading analysis: A novel biomarker for Parkinson's disease progression

Yaisawang S, Attapinan I, Kasetsuwan N, Reinprayoon U, Pongpirul K, Bhidayasiri R, Sringean J.

Parkinsonism Relat Disord. 2025 May;134:107764. doi: 10.1016/j.parkreldis.2025.107764. Epub 2025 Mar 4.

Enteric nervous system dysfunction as a driver of central nervous system disorders: The Forgotten brain in neurological disease

Hajjeh O, Rajab I, Bdair M, Saife S, Zahran A, Nazzal I, AbuZahra MI, Jallad H, Abukhalil MM, Hallak M, Al-Said OS, Al-Braik R, Sawaftah Z, Milhem F, Almur O, Saife S, Aburemaileh M, Abuhilal A.

Neuroscience. 2025 Apr 19;572:232-247. doi: 10.1016/j.neuroscience.2025.03.015. Epub 2025 Mar 13.

Pharmacological landscape of endoplasmic reticulum stress: Uncovering therapeutic avenues for metabolic diseases

Alotaibi G, Alkhammash A.

Eur J Pharmacol. 2025 Jul 5;998:177509. doi: 10.1016/j.ejphar.2025.177509. Epub 2025 Mar 13.

The impact of bright light therapy on Parkinson's disease: A pilot study using vestibular-evoked myogenic potentials

Xie WY, Duan WX, Chen Y, Tao MX, Li HX, Gao F, Yin JY, Yan JH, Wang F, Mao CJ, Shen Y, Liu CF.

Parkinsonism Relat Disord. 2025 May;134:107776. doi: 10.1016/j.parkreldis.2025.107776. Epub 2025 Mar 10.

Intersecting molecular pathways in Synucleinopathies and Amyloidogenesis: Exploring shared mechanisms and therapeutic potential

Kaur J, Sharma V, Khan H, Singh S, Singh TG.

Brain Res. 2025 May 15;1855:149568. doi: 10.1016/j.brainres.2025.149568. Epub 2025 Mar 14.

Integrating virtual reality into multidisciplinary care for Parkinson's disease: A narrative review

Pimenta Silva D, Pona-Ferreira F, Cacho R, Santos B, Lobo T, Bouça-Machado R, Ferreira JJ.

J Parkinsons Dis. 2025 May;15(3):459-479. doi: 10.1177/1877718X251323916. Epub 2025 Mar 16.

NLX-112 Randomized Phase 2A Trial: Safety, Tolerability, Anti-Dyskinetic, and Anti-Parkinsonian Efficacy

Svenningsson P, Odin P, Bergquist F, Wirdefeldt K, Nyholm D, Andréasson M, Markaki I, Johansson AC, Jergil M, Jankosky C, Varney MA, Herbrecht F, Johnson SA, Newman-Tancredi A.

Mov Disord. 2025 Jun;40(6):1134-1142. doi: 10.1002/mds.30175. Epub 2025 Mar 17.

Redefining disease in the age of blood-based biomarkers

Reddy NK.

Front Sociol. 2025 Feb 28;10:1533429. doi: 10.3389/fsoc.2025.1533429. eCollection 2025.

Physical activity and neuroplasticity in neurodegenerative disorders: a comprehensive review of exercise interventions, cognitive training, and AI applications

Ben Ezzdine L, Dhahbi W, Dergaa I, Ceylan Hİ, Guelmami N, Ben Saad H, Chamari K, Stefanica V, El Omri A.

Front Neurosci. 2025 Feb 28;19:1502417. doi: 10.3389/fnins.2025.1502417. eCollection 2025.

Gait and balance worsening after bilateral deep brain stimulation of the subthalamic nucleus (STN-DBS) for Parkinson's disease: a systematic review

Janssen Daalen JM, Selvaraj A, Arnts H, Bloem BR, Bartels RH, Georgiev D, Esselink RAJ, Vinke RS.

BMJ Neurol Open. 2025 Mar 13;7(1):e000898. doi: 10.1136/bmjno-2024-000898. eCollection 2025.

A review of machine learning and deep learning for Parkinson's disease detection

Rabie H, Akhloufi MA.

Discov Artif Intell. 2025;5(1):24. doi: 10.1007/s44163-025-00241-9. Epub 2025 Mar 12.

Dissecting the molecular landscape of Parkinson's disease and Parkinson's disease dementia using highly efficient snRNA-seq (HIF-snRNA-seq)

Kang SU, Park J, Ha S, Kim D, Pletnikova O, Redding-Ochoa J, Troncoso JC, Peng Q, Van Emburgh BO, Trivedi J, Brahmachari S, Nezami B, Dawson VL, Dawson TM.

bioRxiv [Preprint]. 2025 Mar 7:2025.03.01.640894. doi: 10.1101/2025.03.01.640894.

MHCII reduction is insufficient to protect mice from alpha-synuclein-induced degeneration and the Parkinson's HLA locus exhibits epigenetic regulation

Kline EM, Jernigan JE, Scharer CD, Maurer J, Hicks Sl S, Herrick M MK, Wallings RL, Kelly SD, Chang J, Menees KB, McFarland NR, Boss JM, Tansey MG, Joers V.

bioRxiv [Preprint]. 2025 Mar 4:2024.08.31.610581. doi: 10.1101/2024.08.31.610581.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias